NO20014953D0 - Anvendelse av osanetant for fremstilling av medikamenter anvendt for å behandle sinnsstemningslidelser - Google Patents

Anvendelse av osanetant for fremstilling av medikamenter anvendt for å behandle sinnsstemningslidelser

Info

Publication number
NO20014953D0
NO20014953D0 NO20014953A NO20014953A NO20014953D0 NO 20014953 D0 NO20014953 D0 NO 20014953D0 NO 20014953 A NO20014953 A NO 20014953A NO 20014953 A NO20014953 A NO 20014953A NO 20014953 D0 NO20014953 D0 NO 20014953D0
Authority
NO
Norway
Prior art keywords
osanetant
manufacture
drugs used
mood disorders
treat mood
Prior art date
Application number
NO20014953A
Other languages
English (en)
Other versions
NO20014953L (no
Inventor
Xavier Emonds-Alt
Philippe Soubrie
Regis Steinberg
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of NO20014953D0 publication Critical patent/NO20014953D0/no
Publication of NO20014953L publication Critical patent/NO20014953L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
NO20014953A 1999-04-13 2001-10-11 Anvendelse av osanetant for fremstilling av medikamenter anvendt for å behandle sinnsstemningslidelser NO20014953L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9904699A FR2792199B3 (fr) 1999-04-13 1999-04-13 Utilisation de l'osanetant pour la preparation de medicaments utiles dans le traitement des troubles de l'humeur
PCT/FR2000/000924 WO2000061125A2 (fr) 1999-04-13 2000-04-11 L'osanetant dans le traitement des troubles de l'humeur

Publications (2)

Publication Number Publication Date
NO20014953D0 true NO20014953D0 (no) 2001-10-11
NO20014953L NO20014953L (no) 2001-12-11

Family

ID=9544412

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014953A NO20014953L (no) 1999-04-13 2001-10-11 Anvendelse av osanetant for fremstilling av medikamenter anvendt for å behandle sinnsstemningslidelser

Country Status (24)

Country Link
US (1) US6420388B1 (no)
EP (1) EP1175215A2 (no)
JP (1) JP2002541190A (no)
KR (1) KR20010105418A (no)
CN (1) CN1354662A (no)
AR (1) AR023452A1 (no)
AU (1) AU3971600A (no)
BR (1) BR0009704A (no)
CA (1) CA2369638A1 (no)
CZ (1) CZ20013645A3 (no)
EE (1) EE200100527A (no)
FR (1) FR2792199B3 (no)
HR (1) HRP20010741A2 (no)
HU (1) HUP0200655A3 (no)
ID (1) ID30458A (no)
IS (1) IS6098A (no)
MX (1) MXPA01010340A (no)
NO (1) NO20014953L (no)
PE (1) PE20010032A1 (no)
PL (1) PL351554A1 (no)
SK (1) SK14552001A3 (no)
TR (1) TR200102930T2 (no)
WO (1) WO2000061125A2 (no)
ZA (1) ZA200108289B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001095904A1 (en) * 2000-06-12 2001-12-20 University Of Rochester Method of treating symptoms of hormonal variation, including hot flashes, using tachykinin receptor antagonist
WO2005061544A2 (en) * 2003-12-22 2005-07-07 Glaxo Group Limited Nogo-a neutralising immunoglobulins for treatment of neurological diseases
JP2007530591A (ja) * 2004-03-25 2007-11-01 スミスクライン・ビーチャム・コーポレイション 双極性障害を治療するための、ｎｋ３アンタゴニストの使用
EP1867717A4 (en) * 2005-03-15 2008-08-20 Sumitomo Chemical Co METHOD FOR REDUCE SYMPTOM CAUSED BY MUTUAL DISORDER
JP2006320201A (ja) * 2005-05-17 2006-11-30 Sumitomo Chemical Co Ltd 気分障害又は関連障害による疾患症状を改善させる方法
GB0525662D0 (en) 2005-12-16 2006-01-25 Glaxo Group Ltd Immunoglobulins
EP3915560A1 (en) 2014-06-25 2021-12-01 Emory University Methods of managing conditioned fear with neurokinin receptor antagonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2719311B1 (fr) 1994-03-18 1998-06-26 Sanofi Sa Composés antagonistes sélectifs du récepteur NK3 humain et leur utilisation comme médicaments et outils de diagnostic.
FR2729954B1 (fr) * 1995-01-30 1997-08-01 Sanofi Sa Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2738819B1 (fr) * 1995-09-14 1997-12-05 Sanofi Sa Nouveaux composes antagonistes selectifs du recepteur nk3 humain, procede pour leur obtention et compositions pharmaceutiques les contenant
AU4176997A (en) 1996-09-16 1998-04-02 Warner-Lambert Company 3-alkyl-3-phenyl-piperidines

Also Published As

Publication number Publication date
EP1175215A2 (fr) 2002-01-30
PL351554A1 (en) 2003-05-05
TR200102930T2 (tr) 2002-04-22
CZ20013645A3 (cs) 2002-01-16
NO20014953L (no) 2001-12-11
US6420388B1 (en) 2002-07-16
AU3971600A (en) 2000-11-14
FR2792199A1 (fr) 2000-10-20
EE200100527A (et) 2002-12-16
IS6098A (is) 2001-09-28
ZA200108289B (en) 2002-12-24
SK14552001A3 (sk) 2002-02-05
AR023452A1 (es) 2002-09-04
CA2369638A1 (en) 2000-10-19
PE20010032A1 (es) 2001-04-11
HUP0200655A2 (hu) 2002-07-29
JP2002541190A (ja) 2002-12-03
KR20010105418A (ko) 2001-11-28
FR2792199B3 (fr) 2001-05-18
BR0009704A (pt) 2002-01-08
CN1354662A (zh) 2002-06-19
HUP0200655A3 (en) 2002-11-28
MXPA01010340A (es) 2002-05-06
ID30458A (id) 2001-12-06
WO2000061125A3 (fr) 2001-04-19
WO2000061125A2 (fr) 2000-10-19
HRP20010741A2 (en) 2002-10-31

Similar Documents

Publication Publication Date Title
NO20026263L (no) Sulfonyl-pyrrolidin-derivater anvendelige for behandling av neurologiske forstyrrelser
NO20005884L (no) Kombinasjonsterapi for behandling av bipolare forstyrrelser
NO20031442D0 (no) Morfolin-acetamidderivater for behandling av inflammatoriske sykdommer
NO20021845L (no) Behandling av sovnforstyrrelser under anvendelse av desloratadin
DE60031710D1 (de) Fettsäurederivat zur behandlung von externen sekretionsstörungen
NO20031443D0 (no) Forbindelser nyttige for behandling av inflammatoriske sykdommer
NO20024775D0 (no) Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
NO995245L (no) Anvendelse av tetrahydropyridinderivater for fremstilling av medisiner for å behandle sykdommer som bevirker demyelinisering
ATE305451T1 (de) 1-arenesulfonyl-2-aryl-pyrrolidin und piperidin derivative zur behandlung von cns-erkrankungen disorders
NO20020062D0 (no) Behandling av nevrotiske forstyrrelser
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
NO20024777L (no) Kinolinyl-piperidin-4-yliden-metyl-benzamid derivater til behandling av smerte
NO20024776D0 (no) Hydroksyfenyl-piperazinyl-metyl-benzamidderivater til behandling av smerte
NO20014953L (no) Anvendelse av osanetant for fremstilling av medikamenter anvendt for å behandle sinnsstemningslidelser
NO20023803D0 (no) Anvendelse av mirtazapin for behandling av sövnforstyrrelser
NO20020784D0 (no) Medikament for behandling av brudd
NO20032156D0 (no) Behandling av angstforstyrrelser
NO20005216D0 (no) Sammensetning for behandling av eksterne sekresjonssykdommer unntatt hypolakrimasjon
NO20010390D0 (no) Behandling av angstsykdommer
NO20030717L (no) Forbindelser for behandling av avhengighetsforstyrrelser
NO20001894D0 (no) Anvendelse av TNF-antagonister som medikamenter for behandling av septiske sykdommer
NO20012612L (no) Isonipecotamider for behandlingen av integrin-formidlede sykdommer
NO20024331D0 (no) Behandling av lidelser relatert til det serotonerge system
NO20042166L (no) Kombinasjonsterapi for behandling av sykdom
NO20015572D0 (no) Fremgangsmåte til å identifisere terapeutiske forbindelser for behandling av leverlidelser

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application